SCOPUS 정보 검색 플랫폼

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 19, Issue 4, 2011, Pages 302-306

Bisphosphonate-related osteonecrosis of the jaws

(2) Kushner, George M a Alpert, Brian a

a UNIVERSITY OF LOUISVILLE (United States)

Author keywords

bisphosphonate; jaw; osteonecrosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE GLUCONATE; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ETIDRONIC ACID; IBANDRONIC ACID; METRONIDAZOLE; PAMIDRONIC ACID; PENICILLIN G; QUINOLONE DERIVATIVE; RISEDRONIC ACID; TILUDRONIC ACID; ZOLEDRONIC ACID;

CELL ACTIVITY; DEBRIDEMENT; EXTRACORPOREAL LITHOTRIPSY; HUMAN; HYPERBARIC OXYGEN; JAW OSTEONECROSIS; OSTEOBLAST; OSTEOPOROSIS; PATIENT EDUCATION; PATIENT MONITORING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINUS PAIN; TOOTH EXTRACTION; TOOTH PAIN; TOOTH PROSTHESIS;

ADMINISTRATION, ORAL; AGED; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 80051747400 PISSN: 10689508 EISSN: 15316998 Source Type: Journal
DOI: 10.1097/MOO.0b013e328348b257 Document Type: Review

Times cited : (7)

References (18)

1
- 0042861578
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic [1]
- DOI 10.1016/S0278-2391(03)00720-1
- Marx RE. Pamidronate (Aredia) and Zolendronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofacial Surg 2003; 61:1115-1117. (Pubitemid 37064711)
- (2003) Journal of Oral and Maxillofacial Surgery , vol.61 , Issue.9 , pp. 1115-1117
- Marx, R.E.¹

2
- 0027214135
- Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30-, 60-, and 90-mg dosages
- DOI 10.1016/0002-9343(93)90282-T
- Nussbaum SR, Younger J, Vandepol CJ, et al. Single dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30, 60 and 90 mg doses. Am J Med 1993; 95:297-304. (Pubitemid 23270287)
- (1993) American Journal of Medicine , vol.95 , Issue.3 , pp. 297-304
- Nussbaum, S.R.¹ Younger, J.² VandePol, C.J.³ Gagel, R.F.⁴ Zubler, M.A.⁵ Chapman, R.⁶ Henderson, I.C.⁷ Mallette, L.E.⁸

3
- 0035863508
- Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials
- Major P, Lortholary A, Hon J, et al. Zolendronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials. J Clin Oncology 2001; 19:558-567. (Pubitemid 32112871)
- (2001) Journal of Clinical Oncology , vol.19 , Issue.2 , pp. 558-567
- Major, P.¹ Lortholary, A.² Hon, J.³ Abdi, E.⁴ Mills, G.⁵ Menssen, H.D.⁶ Yunus, F.⁷ Bell, R.⁸ Body, J.⁹ Quebe-Fehling, E.¹⁰ Seaman, J.¹¹

4
- 10544228130
- Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases
- DOI 10.1056/NEJM199612123352401
- Hortbagyi GN, Theriault RL, Porter L, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. N Engl J Med 1996; 335:1785-1791. (Pubitemid 26412396)
- (1996) New England Journal of Medicine , vol.335 , Issue.24 , pp. 1785-1791
- Hortobagyi, G.N.¹ Theriault, R.L.² Porter, L.³ Blayney, D.⁴ Lipton, A.⁵ Sinoff, C.⁶ Wheeler, H.⁷ Simeone, J.F.⁸ Seaman, J.⁹ Knight, R.D.¹⁰ Heffernan, M.¹¹ Reitsma, D.J.¹² Kennedy, I.¹³ Allan, S.G.¹⁴ Mellars, K.¹⁵

5
- 7144223389
- Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate
- Hortobagyi GN, Theriault RL, Lipton A, et al. Long term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol 1998; 16:2038-2044. (Pubitemid 28265038)
- (1998) Journal of Clinical Oncology , vol.16 , Issue.6 , pp. 2038-2044
- Hortobagyi, G.N.¹ Theriault, R.L.² Lipton, A.³ Porter, L.⁴ Blayney, D.⁵ Sinoff, C.⁶ Wheeler, H.⁷ Simeone, J.F.⁸ Seaman, J.J.⁹ Knight, R.D.¹⁰ Heffernan, M.¹¹ Mellars, K.¹² Reitsma, D.J.¹³

6
- 2142817155
- Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases
- DOI 10.1016/j.joms.2004.02.004
- Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofacial Surg 2004; 62:527-534. Large review of the manifestations of BRONJ. (Pubitemid 38542516)
- (2004) Journal of Oral and Maxillofacial Surgery , vol.62 , Issue.5 , pp. 527-534
- Ruggiero, S.L.¹ Mehrotra, B.² Rosenberg, T.J.³ Engroff, S.L.⁴

7
- 27344453813
- Bisphosphonate induced exposed bone of the jaws: Risk factors, recognition, prevention and treatment
- Important clinical features and management reviewed
- Marx RE, Sawatari Y, Fortin M, et al. Bisphosphonate induced exposed bone of the jaws: Risk factors, recognition, prevention and treatment. J Oral Maxillofacial Surg 2005; 63:1567-1575. Important clinical features and management reviewed.
- (2005) J Oral Maxillofacial Surg , vol.63 , pp. 1567-1575
- Marx, R.E.¹ Sawatari, Y.² Fortin, M.³

8
- 42149184112
- Inhibition of oral mucosal cell wound healing by bisphosphonates
- DOI 10.1016/j.joms.2008.01.026, PII S0278239108000943
- Landesberg RL, Cozin M, Cremers S, et al. Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofacial Surg 2008; 66:839-847. (Pubitemid 351522817)
- (2008) Journal of Oral and Maxillofacial Surgery , vol.66 , Issue.5 , pp. 839-847
- Landesberg, R.¹ Cozin, M.² Cremers, S.³ Woo, V.⁴ Kousteni, S.⁵ Sinha, S.⁶ Garrett-Sinha, L.⁷ Raghavan, S.⁸

9
- 0037406815
- Bisphosphonate treatment of osteoporosis
- DOI 10.1016/S0749-0690(02)00069-1, PII S0749069002000691
- Watts NB. Bisphosphonate treatment of osteoporosis. Clin Geriatric Med 2003; 19:395-414. (Pubitemid 36514526)
- (2003) Clinics in Geriatric Medicine , vol.19 , Issue.2 , pp. 395-414
- Watts, N.B.¹

10
- 23044489173
- The use of bisphosphonates in osteoporosis
- Delmas PD. The use of bisphosphonates in osteoporosis. Curr Opin Rheumatol 2005; 17:462-466.
- (2005) Curr Opin Rheumatol , vol.17 , pp. 462-466
- Delmas, P.D.¹

11
- 80051759198
- IMS HEALTH, NPA Plus May 2006
- IMS HEALTH, NPA Plus May 2006.

12
- 33847284113
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate Related Osteonecrosis of the Jaws, Advisory Task Force on Bisphosphonate Related Osteonecrosis of the Jaws (updated 2009). Important policy-affecting paper from major involved society
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate Related Osteonecrosis of the Jaws. Advisory Task Force on Bisphosphonate Related Osteonecrosis of the Jaws. J Oral Maxillofacial Surg 2007; 65:369-376 (updated 2009). Important policy-affecting paper from major involved society.
- (2007) J Oral Maxillofacial Surg , vol.65 , pp. 369-376

13
- 34250177225
- Hyperbaric oxygen treatment and bisphosphonate induced osteonecrosis of the jaws: A case series
- DOI 10.1016/j.joms.2007.03.019, PII S0278239107003436
- Frieburger JJ, Padilla-Burgos R, Choe AH, et al. Hyperbaric oxygen treatment and bisphosphonate induced osteonecrosis of the jaws: A case series. J Oral Maxillofacial Surg 2007; 65:1321-1327. (Pubitemid 46907400)
- (2007) Journal of Oral and Maxillofacial Surgery , vol.65 , Issue.7 , pp. 1321-1327
- Freiberger, J.J.¹ Padilla-Burgos, R.² Chhoeu, A.H.³ Kraft, K.H.⁴ Boneta, O.⁵ Moon, R.E.⁶ Piantadosi, C.A.⁷

14
- 64249147273
- Utility of hyperbaric oxygen in the treatment of bisphosphonate related osteonecrosis of the jaw
- Frieburger JJ. Utility of hyperbaric oxygen in the treatment of bisphosphonate related osteonecrosis of the jaw. J Oral Maxillofacial Surg 2009; 67:96-106.
- (2009) J Oral Maxillofacial Surg , vol.67 , pp. 96-106
- Frieburger, J.J.¹

15
- 78751579272
- Initial experience on the outcome of teeth extractions in intravenous bisphosphonate treated patients: A cautionary report
- Scoletta M, Arduino PG, Pol R, et al. Initial experience on the outcome of teeth extractions in intravenous bisphosphonate treated patients: A cautionary report. J Oral Maxillofacial Surg 2011; 69:456-462.
- (2011) J Oral Maxillofacial Surg , vol.69 , pp. 456-462
- Scoletta, M.¹ Arduino, P.G.² Pol, R.³

16
- 77957990077
- Bilateral simultaneous femoral diaphyseal fractures in patients with long term ibandronate use
- Patel VC, Lazzarini AM. Bilateral simultaneous femoral diaphyseal fractures in patients with long term ibandronate use. Orthopedics 2010; 33:775.
- (2010) Orthopedics , vol.33 , pp. 775
- Patel, V.C.¹ Lazzarini, A.M.²

17
- 70449901284
- Bilateral low energy simultaneous femoral fractures in patients on long term alendronate therapy
- Capeci CM, Tejwani NC. Bilateral low energy simultaneous femoral fractures in patients on long term alendronate therapy. J Bone Joint Surg Am 2009; 91:2556-2561.
- (2009) J Bone Joint Surg Am , vol.91 , pp. 2556-2561
- Capeci, C.M.¹ Tejwani, N.C.²

18
- 70349209123
- Atraumatic bilateral femur fractures in long-term bisphosphonate use
- Goddard M, Reid KR, Johnston JC, et al. Atraumatic bilateral femur fractures in long-term bisphosphonate use. Orthopedics 2009; 32:8.
- (2009) Orthopedics , vol.32 , pp. 8
- Goddard, M.¹ Reid, K.R.² Johnston, J.C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.